Table 1 Patient demographic data, stratified by medication type
Azithromycin | Cortico-steroids | Hydroxy-chloroquine | Remdesivir | Tocilizumab | Total | |
|---|---|---|---|---|---|---|
Number of patients | 5,102 | 8,498 | 1,239 | 4,124 | 800 | 9,638 |
Gender | ||||||
Female | 1,984 (38.9%) | 3,324 (39.1%) | 472 (38.1%) | 1,546 (37.5%) | 259 (32.4%) | 3,781 (39.2%) |
Male | 3,118 (61.1%) | 5,174 (60.9%) | 767 (61.9%) | 2,578 (62.5%) | 541 (67.6%) | 5,857 (60.8%) |
Ethnicity | ||||||
Asian | 226 (4.4%) | 298 (3.5%) | 66 (5.3%) | 159 (3.9%) | 34 (4.3%) | 350 (3.6%) |
Black | 770 (15.1%) | 1,241 (14.6%) | 220 (17.8%) | 524 (12.7%) | 105 (13.1%) | 1,455 (15.1%) |
Hispanic | 9 (0.2%) | 15 (0.2%) | 2 (0.2%) | 7 (0.2%) | 3 (0.4%) | 16 (0.17%) |
Other | 1,295 (25.4%) | 2,023 (23.8%) | 277 (22.4%) | 1,063 (25.8%) | 262 (32.8%) | 2,298 (23.8%) |
Natives | 21 (0.4%) | 32 (0.4%) | 5 (0.4%) | 13 (0.3%) | 3 (0.4%) | 35 (0.4%) |
White | 2,781 (54.5%) | 4,889 (57.5%) | 669 (54.0%) | 2,358 (57.2%) | 393 (49.1%) | 5,484 (56.9%) |
Age | ||||||
Median (IQR) | 66 (55–75) | 67 (56–76) | 67 (56–75) | 65 (55–74) | 63 (54–73) | 67 (56–76) |
Range | 18–89 | 18–89 | 24–89 | 18–89 | 18–89 | 18–89 |
BMI | ||||||
Median (IQR) | 29 (26–34) | 29 (26–34) | 29 (26–34) | 30 (26–35) | 30 (26–34) | 29 (25–34) |
Range | 15–45 | 15–45 | 15–45 | 15–45 | 17–45 | 15–45 |